DNLI
Denali Therapeutics Inc.
NASDAQ · Healthcare · Biotechnology · US
$21.17
+8.83%Leverage
- Debt / equity
- 0.03x
- Net debt / equity
- -0.08x
- Debt / assets
- 0.02x
- Debt / EBITDA
- -0.05x
- Net debt / EBITDA
- 0.16x
Liquidity & coverage
- Current ratio
- 6.21x
- Quick ratio
- 5.94x
- Cash ratio
- 5.42x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $496.4M
Cash & dividend
- FCF / debt
- -18.20x
- Cash flow / debt
- -17.96x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Sep 1, 2026